Andrea Blesio - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrea Blesio

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

International Immunopharmacology|January 11, 2026

Target validation of natural compounds: Perillaldehyde case studyAndrea Blesio, Carmine Giorgio, Stefano Sala, et al.

Biochemical Pharmacology|October 5, 2025

Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replicationAlfonso Zappia, Francesca Romana Ferrari, Carmine Giorgio, et al.

Biochemical Pharmacology|February 15, 2026

The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

International Immunopharmacology|January 11, 2026

Target validation of natural compounds: Perillaldehyde case studyAndrea Blesio, Carmine Giorgio, Stefano Sala, et al.

Biochemical Pharmacology|October 5, 2025

Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replicationAlfonso Zappia, Francesca Romana Ferrari, Carmine Giorgio, et al.

Biochemical Pharmacology|February 15, 2026

The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.

Pageof 1